NeuMoDx Announces CE Marking for SARS-COV2 Test

NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on providing high throughput testing solutions to hospital and commercial reference laboratories, announced it has secured the regulatory CE Mark approval for its NeuMoDx™ SARS-CoV-2 Assay implemented on the NeuMoDx™ Molecular Systems.